Breaking News

Ranbaxy to Deploy Instem’s Preclinical Software

Will automate lab processes at R&D headquarters in India

Ranbaxy Laboratories has purchased Instem’s Provantis preclinical software suite to automate lab processes at its R&D headquarters in Gurgaon, India. Provantis modules to be deployed include Inlife, Pathology, Tables & Statistics, Clinical Pathology, Protocol & Report Assembly, which will replace in-house developed applications. 
 
Neil Donaldson, Instem’s vice president of global sales, Europe & Asia, said, “We are delighted to welcome Ranbaxy as our newest client in the Asia Pacific region and look forward to a long and successful partnership. Instem recognizes the increasingly important role that Indian organizations play in the global pharmaceutical market and we are committed to supporting the future growth and development of the Indian R&D community.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters